Other ETF

Nippon India Nifty Pharma ETF · Direct Growth

Nippon India Mutual Fund

· 20 Nov 2026
₹29.1863
+11.04%
+8.47%
+15.80%
+3.82%
+25.57%
+2.08%
+21.63%
+13.87%
+16.63%
+8.97%
Grey:

Nippon India Nifty Pharma ETF · Direct Growth, in plain words

  • This is an other etf from Nippon India Mutual Fund.
  • Over the last 5 years it returned +16.63% a year, above the of +8.97% ( 3 of 19).
  • Its was 21.0%, from Oct 2021 to Mar 2023; it took 4 months from the bottom to get back to its old high.
  • Across 589 in its history, money invested made a gain in 100% of them and earned 7% a year or more in 100%.

Written from AMFI and NAV-history numbers. It describes the past; it is not a forecast or a recommendation.

20 Nov 2026
₹29.1863
+79.95% over 3Y

How bumpy has the ride been?

From every daily NAV since launch, not just today's 1Y / 3Y / 5Y snapshot.

−21.0%
Oct 2021 → Mar 2023
4 months
back at its high by Jul 2023
-15.30%
to Jul 2022
15.1%
typical yearly swing either way
589 windows, each as a yearly return ()
Worst +12.81%Typical +20.51%Best +27.64%
100%
of 3-year periods ended with a gain
100%
earned 7% a year or more (about an FD)

calculator

Started
Invested
₹3,00,000
Value today
₹5,04,298
Gain
+₹2,04,298
+20.90%

60 monthly instalments from 22 Nov 2021, each bought at that day's NAV (the next one on a holiday), valued at the NAV of 20 Nov 2026. Exit load and taxes are not deducted. Past returns do not indicate future returns.

Step-up SIP and a growth chart: open the full SIP calculator →
Nippon India Mutual Fund
Other ETF
Direct · Growth
INF204KC1089
149008
NAV history since6 Jul 2021
+14.02% a year

Other Other ETF direct plans

All Other ETF plans →

NAV from AMFI, history from mfapi.in. Returns under a year are absolute, from a year up annualised (CAGR). ShareSetu does not sell or recommend funds; nothing here is investment advice. Read the scheme documents before investing. Every term explained →